Renal Denervation Researcher Argues Sham Control Is Ethically Necessary
This article was originally published in The Gray Sheet
Executive Summary
The lead investigator on the SYMPLICITY HTN-3 trial says sham-controlled trials are sometimes ethically necessary to prevent patients from undergoing ineffective treatments and warns there may be other medical devices on the market that are not as effective as previously thought.